As for sEH, it catalyzes the metabolism of EETs, which exhibit potentially beneficial actions in stroke via vasodilation, neuroprotection, promotion of angiogenesis, suppression of platelet aggregation, oxidative stress, and post-ischemic inflammation [120]. This evidence concerns the gene EPHX2 and stroke disorder.